Michael Barbella, Managing Editor03.15.24
The United States Patent and Trademark Office has issued a patent to electroCore Inc. relating to systems and methods for treating post-traumatic stress disorder (PTSD).
U.S. Patent No. 11,865,329, “Vagal Nerve Stimulation for Treating Post-Traumatic Stress Disorder,” generally relates to methods for treating PTSD symptoms that include applying one or more electrical impulses transcutaneously to the vagus nerve for approximately 90 seconds to approximately three minutes. The electrical impulses may comprise bursts of two to 20 pulses.
electroCore Inc. is a commercial stage bioelectronic medicine and wellness company dedicated to improving health through its non-invasive vagus nerve stimulation (nVNS) technology platform. It aims to commercialize medical devices for managing and treating certain medical conditions and consumer product offerings utilizing nVNS to promote general wellbeing and human performance.
U.S. Patent No. 11,865,329, “Vagal Nerve Stimulation for Treating Post-Traumatic Stress Disorder,” generally relates to methods for treating PTSD symptoms that include applying one or more electrical impulses transcutaneously to the vagus nerve for approximately 90 seconds to approximately three minutes. The electrical impulses may comprise bursts of two to 20 pulses.
electroCore Inc. is a commercial stage bioelectronic medicine and wellness company dedicated to improving health through its non-invasive vagus nerve stimulation (nVNS) technology platform. It aims to commercialize medical devices for managing and treating certain medical conditions and consumer product offerings utilizing nVNS to promote general wellbeing and human performance.